STATE STREET CORP 8-K
Research Summary
AI-generated summary
State Street Corp Reports 2026 Annual Meeting Vote Results
What Happened State Street Corporation filed an 8-K reporting results from its Annual Meeting held May 20, 2026. A total of 240,977,249 shares were represented (about 86.98% of the 277,035,190 shares outstanding as of the March 25, 2026 record date). Shareholders elected all thirteen director nominees, approved the advisory “say-on-pay” proposal on executive compensation, ratified Ernst & Young LLP as the independent registered public accounting firm for 2026, and rejected a shareholder proposal to require the Board Chair be independent at the next CEO transition.
Key Details
- Shares represented: 240,977,249 (86.98% of 277,035,190 outstanding as of March 25, 2026). Broker non-votes: 17,269,746.
- Directors elected (all 13 nominees): Marie A. Chandoha; DonnaLee A. DeMaio; Amelia C. Fawcett; William C. Freda; Susan M. Gordon; Patricia M. Halliday; Sara Mathew; William L. Meaney; Ronald P. O'Hanley; Sean O'Sullivan; Julio A. Portalatin; Brian J. Porter; John B. Rhea. Vote totals varied by nominee (each elected).
- Advisory vote on executive compensation (Proposal 2): 207,894,340 FOR (93.2% of votes cast), 15,187,360 AGAINST, 625,803 abstentions.
- Ratification of Ernst & Young as auditor (Proposal 3): 221,395,564 FOR (91.9% of votes cast), 19,494,699 AGAINST, 86,986 abstentions.
- Shareholder proposal to require an independent Board Chair at next CEO transition (Proposal 4): 51,352,459 FOR (23.1%), 171,324,674 AGAINST, 1,030,370 abstentions.
Why It Matters These results confirm board continuity and investor support for management’s compensation program and choice of auditor, which are routine but important governance outcomes. The decisive rejection of the independent-chair proposal means State Street’s current practice for selecting the Board Chair remains unchanged for now. High participation (~87% turnout) shows strong shareholder engagement, which can affect future governance discussions and proxy-season priorities.
Loading document...